Biotech

All Articles

Sanofi's $80M bet on Fulcrum dystrophy medication finishes in period 3 lose big

.Simply four months after Sanofi bet $80 thousand in upfront cash on Key Therapies' losmapimod, the ...

Oncternal share drains 60% surrounded by unemployments, trial discontinuations

.Cancer cells business Oncternal Therapies is actually folding all its own medical trials and also l...

Roche is actually supporting out hopes that its injectable being overweight prospect might inevitably illustrate 25% weight reduction in late-stage test

.Roche is actually holding out hopes that its injectable obesity prospect could inevitably display 2...

Novo Nordisk barrages 'exceptional' fat loss result for dual-acting oral drug in very early test

.Novo Nordisk has actually elevated the top on a period 1 test of its own oral amylin and GLP-1 rece...

AbbVie sues BeiGene over blood cancer cells medication classified information

.Simply a handful of brief weeks after winning an FDA Fast lane tag for its own investigational BTK ...

Lilly supplies one-two strike with 2nd tranche of positive data on weekly insulin prospect

.Not long after a good data drop for Eli Lilly's efsitora alfa, the Indianapolis-based firm is once ...

BridgeBio reduces gene treatment spending plan as scientific data let down

.BridgeBio Pharma is actually lowering its genetics treatment finances as well as drawing back from ...

GSK gives up HSV vaccination hopes after stage 2 fail, delivering ethnicity to Moderna, BioNTech

.GSK's attempt to build the first vaccine for herpes simplex infection (HSV) has actually ended in f...

GSK's long-acting breathing problem drug cut in half assaults in period 3

.GSK's long-acting breathing problem treatment has actually been actually revealed to halve the vari...

AstraZeneca, Daiichi unbox Dato-DXd's total survival neglect

.AstraZeneca and also Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually fal...